MBA-P01 (Botulinum toxin A)
Sponsors
Medy-Tox, Medytox Korea
Conditions
Glabellar Frown Lines
Phase 2
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
CompletedNCT04143815
Start: 2019-05-20End: 2020-09-01Updated: 2021-03-19
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
CompletedNCT05217355
Start: 2021-12-28End: 2022-06-22Updated: 2023-02-24